The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial

Emery, Paul; Fleischmann, Roy; Filipowicz‐Sosnowska, Anna; Schechtman, Joy; Szczepański, L; Kavanaugh, Arthur; Racewicz, Artur; van Vollenhoven, Ronald; F. Li, Nicole; Agarwal, Sunil; Hessey, E.; Shaw, T

doi:10.1002/art.21778

Public

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial

Published in Arthritis & Rheumatism • Apr 28, 2006

Authors:

Paul Emery

Roy Fleischmann

Anna Filipowicz‐Sosnowska

Abstract

OBJECTIVE: To examine the efficacy and safety of different rituximab doses plus methotrexate (MTX), with or without glucocorticoids, in patients with active rheumatoid arthritis (RA) resistant to disease-modifying antirheumatic drugs (DMARDs), including biologic agents. METHODS: A total of 465 patie...

Subject

Medicine

Rheumatoid arthritis

Rituximab

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!